Market Cap (In AUD)
90.3 Million
Revenue (In AUD)
2.59 Million
Net Income (In AUD)
-5.47 Million
Avg. Volume
131.67 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.465-0.985
- PE
- -14.1
- EPS
- -0.05
- Beta Value
- 0.734
- ISIN
- AU0000150328
- CUSIP
- -
- CIK
- -
- Shares
- 128092999.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Liz Dallimore B.Sc., M.B.A., Ph.D.
- Employee Count
- -
- Website
- https://argenica.com.au
- Ipo Date
- 2021-06-11
- Details
- Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. The company was incorporated in 2019 and is based in Nedlands, Australia.
More Stocks
-
PCJEWELLERPC Jeweller Limited
PCJEWELLER
-
131970Tesna Inc.
131970
-
EMWPFEros Media World Plc
EMWPF
-
QQQFFQuizam Media Corporation
QQQFF
-
NXGBNxGen Brands Inc.
NXGB
-
KOS
-
123690Hankook Cosmetics Co., Ltd.
123690
-
OTCFF